More recently, an increased risk of ovarian cancer was found with CRP > 10 mg/dl within 7 years of the assay53, and a high baseline CRP level (> 3 mg/L) implicated an 80% greater risk of early death from cancer54. Here, CRP is linked to ovarian carcinoma.